Proper reform is needed of the appeals process at the US Food and Drug Administration's device centre
This article was originally published in SRA
Executive Summary
Jeffrey Shapiro, Jeffrey Gibbs and Jennifer Newberger find that while new draft guidance on the US FDA's device centre's appeals process is helpful, it does not go far enough. Actual reform is badly needed, they say.